| Type | Value |
|---|---|
| cik | 0000721994 |
| ticker | LKFN |
Discretionary BUY minus SELL in USD over rolling windows. Excludes compensation flow.
| Date | Type | Insider | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | SALE | Toothaker Bradley J | 5,900 | 60.62 USD | |
| 05 May 2026 | GRANT_AWARD | Abbasi Faraz | 21 | 61.92 USD | deriv |
| 05 May 2026 | GRANT_AWARD | Augsburger Blake | 163 | 61.92 USD | deriv |
| 05 May 2026 | GRANT_AWARD | Christian Darrianne P | 46 | 61.92 USD | deriv |
| 05 May 2026 | GRANT_AWARD | PICHON EMILY E | 7 | 61.92 USD | deriv |
| 05 May 2026 | SALE | ROSS STEVEN D | 19 | 62.50 USD | |
| 06 May 2026 | SALE | ROSS STEVEN D | 1,281 | 62.50 USD | |
| 05 May 2026 | GRANT_AWARD | WELCH M SCOTT | 510 | 61.92 USD | deriv |
| 05 May 2026 | GRANT_AWARD | Smith Brian J | 176 | 61.92 USD | deriv |
| 05 May 2026 | GRANT_AWARD | Toothaker Bradley J | 160 | 61.92 USD | deriv |
| 05 May 2026 | GRANT_AWARD | Starr Daniel Brian | 4 | 61.92 USD | deriv |
| 05 May 2026 | GRANT_AWARD | Truex Melinda Jo | 88 | 61.92 USD | derivindirect |
| 12 Mar 2026 | PURCHASE | WELCH M SCOTT | 10,000 | 56.23 USD | indirect |
| 09 Mar 2026 | PURCHASE | WELCH M SCOTT | 5,000 | 55.45 USD | indirect |
| 27 Feb 2026 | PURCHASE | WELCH M SCOTT | 10,000 | 57.95 USD | indirect |
| 23 Feb 2026 | SALE | Toothaker Bradley J | 5,685 | 58.36 USD | |
| 05 Feb 2026 | GRANT_AWARD | Starr Daniel Brian | 3 | 62.10 USD | deriv |
| 05 Feb 2026 | GRANT_AWARD | Toothaker Bradley J | 158 | 62.10 USD | deriv |
| 05 Feb 2026 | GRANT_AWARD | WELCH M SCOTT | 505 | 62.10 USD | deriv |
| 05 Feb 2026 | GRANT_AWARD | PICHON EMILY E | 8 | 62.10 USD | deriv |
| 05 Feb 2026 | GRANT_AWARD | Augsburger Blake | 160 | 62.10 USD | deriv |
| 05 Feb 2026 | GRANT_AWARD | Smith Brian J | 173 | 62.10 USD | deriv |
| 05 Feb 2026 | GRANT_AWARD | Truex Melinda Jo | 87 | 62.10 USD | derivindirect |
| 05 Feb 2026 | GRANT_AWARD | Christian Darrianne P | 45 | 62.10 USD | deriv |
| 05 Feb 2026 | GRANT_AWARD | Abbasi Faraz | 21 | 62.10 USD | deriv |